Navigation Links
Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
Date:8/22/2013

development-and-worldwide-license-agreement-for-investigational-anti-cancer-drug-pci-32765">December 2011 to co-develop and co-commercialize ibrutinib.

About Pharmacyclics
Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. The company is committed to high standards of ethics, scientific rigor, and operational efficiency as it moves each of these programs to viable commercialization.

Pharmacyclics is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements, including our expected liquidity position and timing of the receipt of certain milestone payments, and the sufficiency of our current assets to meet these requirements, our futu
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
2. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
3. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
4. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
5. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
6. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
7. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
10. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
11. Recent Study Reveals Physicians Prefer Topical Delivery for Drug Delivery Technology, Such as a Transdermal Patch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that it ... $3.3 million at a price of $0.30 per unit. ... investor. Each unit consists of one common share and ... Each whole warrant entitles the holder to acquire one ... period of five years from closing.  ...
(Date:11/26/2014)... 26, 2014 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... of previously announced concurrent financing transactions resulting in ... estimated offering expenses, Lexicon anticipates net proceeds of ... consisted of: , a public offering ... a registration statement that has been declared effective ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... , Increased vaccination ... gaps remain, others must join effort , DAVOS, Switzerland ... announced today that their foundation will commit $10 billion ... deliver vaccines for the world,s poorest countries. , (Photo: ...
... , , REDWOOD CITY, Calif. ... today announced financial results for its fiscal second quarter and six months ... call at 4:30 p.m. Eastern Time to discuss the financial ... quarter, as we continued to transition the sales model for our cardiac ...
Cached Medicine Technology:Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 2Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 3Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 4Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 5Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 2Cardica Announces Fiscal 2010 Second Quarter Financial Results 3Cardica Announces Fiscal 2010 Second Quarter Financial Results 4Cardica Announces Fiscal 2010 Second Quarter Financial Results 5Cardica Announces Fiscal 2010 Second Quarter Financial Results 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 7Cardica Announces Fiscal 2010 Second Quarter Financial Results 8Cardica Announces Fiscal 2010 Second Quarter Financial Results 9
(Date:11/28/2014)... 2014 (HealthDay News) -- Planning on seconds at Thanksgiving ... -- clinically known as gastroesophageal reflux disease (GERD) -- a ... Josephson, an ear, nose and throat specialist at Lenox Hill ... help manage GERD on Thanksgiving: Pace yourself. ... two small meals throughout the day. It,s also a good ...
(Date:11/28/2014)... Not only is the Éminence Organic Skin Care ... and other cancer-causing agents, but they are also proud ... programs that help in the fight against breast cancer. ... incredible, record-breaking contribution of $30,000 through participation in the ... Red Rose Whip Moisturizer and the company’s corporate donation. ...
(Date:11/28/2014)... 28, 2014 An inventor and dental assistant ... a patient’s filling and it was almost impossible to reach. ... light," she said. , The patent-pending Access Light allows for ... to areas of the mouth, as well as avoids harm ... safety. Easy to use and clean, it also helps prevent ...
(Date:11/28/2014)... 28, 2014 Mabel’s Labels , ... lose® and an award-winning company established by four moms, ... Esp, and Tricia Mumby have been honored with a ... with the PROFIT Award for Excellence in Entrepreneurship. , ... and Tricia Mumby) accepted the award on behalf of ...
(Date:11/28/2014)... A newly released article from Community ... influenza virus that will soon be spreading across the United ... begins with a brief explanation of what the influenza virus ... that children under the age of 5, adults over the ... as heart and lung diseases, asthma, or diabetes, are at ...
Breaking Medicine News(10 mins):Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... , , LOS ANGELES, Sept. 10 ... tune into DietTribe , Lifetime,s reality series about a group of ... two premieres Friday, October 2nd at 9:00pm ET/PT . ... Kaiser return to guide and coach an all-new tribe as they work ...
... , , CHICAGO, Sept. 10 The ... , Is anyone listening? As this debate rages on about ... every day, we do not hear about what is happening to the people ... , Two million people in the U.S. died ...
... , NEW YORK, Sept. 10 , , , What: ... Americans could come down with the swine flu this fall and, ... that by July, more, than ... hospitalized. With fears that swine flu will become a, ...
... , , ... For the 21(st) consecutive year Polaroid, under the new ownership of PLR ... Boston Marathon Jimmy Fund Walk. , , On Sunday, September ... the world, will be there as Boston Marathon Jimmy Fund Walk participants follow ...
... , , ST. LOUIS, ... management, business intelligence and performance management solutions announced that ... portal for BlueAdvantage Administrators of Arkansas to enable greater ... The intranet portal will provide BlueAdvantage employees the ability ...
... flu, H1N1 goes deep into respiratory tract, researchers confirm ... research confirms previous reports that the H1N1 swine flu ... possibly explaining why it,s often more severe in some ... the current pandemic have experienced relatively mild symptoms," Ten ...
Cached Medicine News:Health News:Get Pumped Up for the Return of 'DietTribe' Season Two of Inspirational Lifestyle Series Premieres October 2 on Lifetime Television 2Health News:Get Pumped Up for the Return of 'DietTribe' Season Two of Inspirational Lifestyle Series Premieres October 2 on Lifetime Television 3Health News:Medical Holocaust in U.S.: Who in the Health Cares? 2Health News:Medical Holocaust in U.S.: Who in the Health Cares? 3Health News:Insite Security Hosts Webinar on Swine Flu Preparedness 2Health News:Polaroid(R) Continuing Tradition of Support for Boston Marathon(R) Jimmy Fund(R) Walk 2Health News:Amitech Solutions Selected to Implement SharePoint Portal for BlueAdvantage Administrators of Arkansas 2Health News:Amitech Solutions Selected to Implement SharePoint Portal for BlueAdvantage Administrators of Arkansas 3Health News:Swine Flu Burrows Into Lungs: Study 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: